Funding
Seed+Non-Dilutive · Biotech

Cellbricks Therapeutics secures €10M seed and non-dilutive package

Cellbricks Therapeutics secured €10 million in combined seed and non-dilutive financing announced in March.

Updated Oct 16, 2026By RoundOS Funding desk

b2venture, LifeX Ventures, Brandenburg Kapital, High-Tech Gründerfonds and Atlantic Labs are among its backers.

The company develops biofabricated human tissue implants and is working toward 3D-printed organs.

Funding history

Seed+Non-Dilutive · This round€10M

Sources

  1. Cellbricks Therapeuticsprojectstartups.com
  2. tech.eu

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related